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Objective: We examined the influence of shunt size on regulation of the pulmonary
blood flow in a canine model of a univentricular heart because specific guidelines
regarding suitable shunt size in the Norwood operation remain undetermined.
Methods: Beagle dogs (n  8) 3 to 7 months old and weighing 3.0 to 5.0 kg were
used. Atrial septectomy and patch closure of the tricuspid valve were performed,
and a systemic–pulmonary arterial shunt was created by interposing a 3.5- or
4.0-mm graft between the right subclavian artery and main pulmonary artery. After
cardiopulmonary bypass, hemodynamic variables including pulmonary and sys-
temic blood flow were measured consecutively according to physiologically respi-
ratory manipulations. The ratio of shunt size to body weight ranged from 0.80 to
1.33 mm/kg (1.08  0.16 mm/kg).
Results: Each dog with a ratio of shunt size to body weight of 0.8 to 1.1 showed
significant negative correlation between the pulmonary/systemic blood flow ratio and
arterial PCO2, but those with a ratio of shunt size to body weight of 1.1 to 1.4 did not.
Consequently each dog with a ratio of shunt size to body weight of 0.8 to 1.0 got
adequate systemic flow, whereas a ratio of 1.0 to 1.4 resulted in inadequate systemic
flow and acidic status. Similar phenomena were shown with the grouped data on
relationship between the pulmonary/systemic blood flow ratio and inspired oxygen
fraction.
Conclusions: These findings imply that when the ratio of shunt size to body weight
is 0.8 to 1.1, the pulmonary/systemic blood flow ratio is controllable by physiologic
respiratory manipulations. Larger shunts make pulmonary blood flow excessive and
uncontrollable. We recommend that a ratio of shunt size to body weight of 0.9 to 1.0
be considered a useful index for suitable systemic–pulmonary arterial shunt in the
Norwood operation.
Since Norwood and colleagues’ initial publication,1 staged reconstruc-tion for patients with hypoplastic left heart syndrome has been achievedaccording to several rationales and technical evolutions, and its outlookhas dramatically improved with time.2-5 Contemporarily, however, themost problematic and controversial step in the staged-approach re-mains optimal pulmonary blood flow in the first stage of palliation.5-7
The size of the systemic–pulmonary arterial shunt, PaCO2, and inspired oxygen
fraction (FIO2) may all play roles in controlling the pulmonary blood flow.2,6-11
Generally speaking, the use of a smaller shunt in the first-stage palliative surgery
is advocated clinically because larger shunts are associated with high incidence of
acute cardiovascular collapse and mortality.2,6,7,12,13 However, the specific guide-
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lines for suitable shunt size remain undefined. Our aim was
to elucidate the role of shunt size in regulation of the
pulmonary blood flow and to determine a useful index for
an optimal size of systemic–pulmonary arterial shunt in the
first-stage palliative surgery with a canine model of the
univentricular heart.
Material and Methods
Animal Preparation
Female beagle dogs (n  8) 3 to 7 months old and weighing 3.0
to 5.0 kg were used. All animals received humane care in com-
pliance with the “Guide for the Care and Use of Laboratory
Animals” prepared by the Institutes of Laboratory Animal Re-
sources, National Research Council, and published by National
Academy Press, revised 1996.
Each dog was anesthetized with pentobarbital sodium (5 mg/kg
intravenously), fentanyl (0.05 mg/kg intravenously), and pancuro-
nium bromide (0.1 mg/kg intravenously). Mechanical ventilation
was instituted with initial settings of FIO2 of 0.3, rate of 12
breaths/min, peak inspiratory pressure of 12 cm H2O, and positive
end-expiratory pressure of 3 cm H2O (model IV-100B; Sechrist,
Anaheim, Calif). Anesthesia was maintained with fentanyl (0.05
mg/[kg  h] intravenously) and pancuronium bromide (0.5 mg/[kg
 h] intravenously).
A 4F plastic catheter was inserted into the descending aorta
from the femoral artery for systemic arterial blood pressure mon-
itoring and arterial blood gas sampling. Another 4F catheter was
placed into the inferior vena cava from the femoral vein for central
venous pressure monitoring.
With the animal in the supine position, the heart and great
vessels were exposed through a midline sternotomy. A 4F catheter
was inserted into the left atrium for left atrial pressure monitoring,
and an another catheter was placed into the main pulmonary artery
from the infundibulum of the right ventricle for pulmonary arterial
pressure monitoring.
The animal model of the univentricular heart was prepared in
accordance with the procedure of Mora and colleagues9 (Figure 1).
After systemic heparinization (0.3 mL/kg), a 3.5- or 4.0-mm
microknitted Dacron polyester fabric graft (Golaski vascular pros-
thesis; Golaski Laboratories, Philadelphia, Pa) with 30 to 40 mm
length was anastomosed end to side to the origin of the right
subclavian artery. Cardiopulmonary bypass (CPB) was then initi-
ated by placing the arterial cannula in the ascending aorta and
placing the venous cannula into the right atrium. Pump flow was
maintained between 100 and 150 mL/(kg  min), and mean arterial
pressure was maintained between 40 and 70 mm Hg. While the
animal was being cooled to a pharyngeal temperature of 18 to
20°C, another side of the graft was anastomosed to the main
pulmonary artery. The shunt was clamped until the animal was
halfway weaned from CPB. After completion of hypothermia,
cardiac arrest was obtained by topical cooling with iced slush, and
then the circulation was arrested. After a right atriotomy, an atrial
septectomy and suturing of a patch to the anulus of the tricuspid
valve were performed to exclude the right ventricle from the
circulation. After the right atriotomy was closed, the animal was
placed back on CPB and rewarmed to a pharyngeal temperature of
37°C. The heart was defibrillated as needed. During rewarming,
hemoconcentration was performed by the extracorporeal ultrafil-
tration method until the hematocrit value was 35% to 45%. When
pump flow was decreased to half after completion of rewarming,
the clamp of the systemic–pulmonary arterial shunt was released
and ventilation was resumed with FIO2 of 1.0. When hemodynam-
ics were satisfactory, the animal was weaned from CPB with the
administration of dopamine in doses of 5 g/(kg  min).
This experiment constitutes a set of consecutive animal prep-
arations with equal technical success. All animals were killed after
data acquisition.
Data Acquisition
Arterial blood gas values, pH, base excess, and hematocrit were
measured with a blood gas and hematocrit analyzer (GEM STAT;
Mallinckrodt Inc, Ann Arbor, Mich). Pulmonary and systemic
arterial, central venous, and left atrial pressures were measured
with a polygraph system (AP-641G; Nihon Kohden Corporation,
Tokyo, Japan). Mean pressure was obtained by electrical integra-
Figure 1. Preparation of canine model of univentricular heart.
Atrial septectomy (A), patch closure of tricuspid valve anulus (B),
and systemic–pulmonary arterial shunt (C) are performed to ex-
amine characteristics of pulmonary blood flow dynamics in uni-
ventricular parallel circulations. Note that right subclavian artery
is third branch of first head vessel from aortic arch, unlike in
human beings. For direct measurements of aortic and pulmonary
blood flow, electromagnetic flowmeter probes are adjusted tan-
gentially around ascending aorta and shunt graft, respectively.
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tion. Pulmonary blood flow (Q˙ p) and aortic blood flow were
measured directly with the electromagnetic flowmeters (MFV-
1200; Nihon Kohden) with flow probes placed around the graft as
a systemic–pulmonary arterial shunt and the middle level of the
ascending aorta, respectively. Systemic blood flow (Q˙ s) was cal-
culated as aortic blood flow minus pulmonary blood flow. Pulmo-
nary and systemic vascular resistances were calculated by standard
formulas.
Experimental Protocol
After about 30 minutes of observation with stable univentricular
hemodynamics, respiratory interventions for the change of the
pulmonary/systemic resistance ratio were begun. The hemody-
namic variables (systemic arterial blood pressure, pulmonary ar-
terial pressure, central venous pressure, left atrial pressure, Q˙ p, and
Q˙ s) were measured consecutively, and systemic arterial blood gas
analysis was performed simultaneously during voluntary changes
in the respiratory conditions (FIO2, respiratory rate, peak inspira-
tory pressure). FIO2 was intermittently set at 0.21, 0.4, 0.5, 0.7, 0.8,
and 1.0. The respiratory rate and peak inspiratory pressure were
changed between 12 and 30 breaths/min and between 11 and 18
cm H2O, respectively, then PaCO2 was changed between 25 and 70
mm Hg.
Data Analysis and Statistics
The values obtained within 15 minutes of changing the respiratory
conditions were excluded from the data analysis. StatView (ver-
sion 4.5; SAS Institute, Inc, Cary, NC) was used to calculate
analytic statistics. Linear regression analysis was used to deter-
mine the correlation between the ratio of Q˙ p to Q˙ s and PaCO2,
hematocrit, and base excess. One-way analysis of variance was
used to analyze the relationship between the ratio of Q˙ p to Q˙ s and
FIO2.
Results
The measured and calculated hemodynamic variables after
weaning from CPB in all canine models under all respira-
tory conditions are shown in Table 1. We considered them
to fall within a reasonable range as the univentricular he-
modynamics of beagle dogs compared with those of a
similar previous animal model.9
The ratio of shunt size (in millimeters) and body weight
(in kilograms; SS/BW ratio) was used to assess the influ-
ences of shunt size on the regulation of the pulmonary blood
flow. We used a 3.5-mm graft in one dog and 4.0-mm graft
in 7 dogs at random, and the body weight of each animal
scattered SS/BW ratio from 0.80 to 1.33 (1.08  0.16)
(Table 2). We divided all canine models into two groups
according to SS/BW ratio. The group of animals in which
the SS/BW ratio was 0.8 to 1.1 was defined as the small
shunt group and consisted of 4 dogs. The group of animals
in which the SS/BW ratio was 1.1 to 1.4 was defined as the
large shunt group and also consisted of 4 dogs.
We drew the actual curves of Q˙ p/Q˙ s ratio versus PaCO2
for each of the 8 animals, and the composite results by
group are shown in Figure 2. When the SS/BW ratio was
less than 1.1, there was a significant negative correlation
between Q˙ p/Q˙ s ratio and PaCO2 of each dog. When SS/BW
ratio was larger than 1.1, however, there was no correlation
between Q˙ p/Q˙ s ratio and PaCO2 of each dog. The regulation
of Q˙ p with ventilatory manipulations in each of the animals
with the SS/BW ratio less than 1.0 resulted in adequate Q˙ s
(Figure 3). The smaller the SS/BW ratio became, the more
the value of Q˙ s changed with the value of PaCO2. When
SS/BW ratio was greater than 1.0, however, there was no
significant correlation between the Q˙ s and PaCO2 of each
animal.
The influence of FIO2 on the Q˙ p/Q˙ s ratio is shown in
Figure 4. In the small shunt group, as FIO2 became higher
from 0.21 to 0.7, the Q˙ p/Q˙ s ratio increased significantly
from 1.31  0.20 to 1.76  0.13 (P  .01). In the large
shunt group, however, no correlation was found.
The change of hematocrit between 35% and 45% did not
produce any significant difference in the Q˙ p/Q˙ s ratio in
either group. That is to say, usual hemoconcentration was of
weak significance as a regulator of pulmonary blood flow
despite the augmented viscosity and should be expected to
increase oxygen supply in the limited pulmonary blood flow
of the univentricular hemodynamics.
TABLE 1. Hemodynamic variables in all canine models
after weaning from cardiopulmonary bypass
Mean  SD
Mean pulmonary arterial pressure (mm Hg) 16 3
Mean systemic arterial pressure (mm Hg) 58 10
Central venous pressure (mm Hg) 9 3
Left atrial pressure (mm Hg) 8 3
Q˙p (mL  kg1  min1) 141.3 35.0
Q˙s (mL  kg1  min1) 126.2 45.4
Q˙p/Q˙s 1.350 0.81
Pulmonary vascular resistance
(dyne  s  cm5  kg)
4528 2641
Systemic vascular resistance
(dyne  s  cm5  kg)
33,547 12,950
TABLE 2. Group characteristics using shunt size/body
weight ratio
Body weight
(kg)
Shunt size
(mm)
SS/BW
ratio
Small shunt group (group S)
3.6 3.5 0.97
3.7 4.0 1.08
4.0 4.0 1.00
5.0 4.0 0.80
Large shunt group (group L)
3.0 4.0 1.33
3.4 4.0 1.81
3.5 4.0 1.14
3.5 4.0 1.14
SS/BW, Shunt size/body weight.
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There was no correlation between the Q˙ p/Q˙ s ratio and
base excess in either group. In the small shunt group,
however, the base excess ranged from 8 to 6 and was
distributed within the physiologically homeostatic range,
whereas in the large shunt group it ranged from 12 to 2
and was distributed within the severely acidic range (Figure 5).
Figure 2. Relationship between arterial carbon dioxide tension (PaCO2) and pulmonary/systemic blood flow ratio
(Qp/Qs) of each dog. There is a significant negative correlation in group S (A, SS/BW ratio of 0.8-1.1). Triangles,
Qp/Qs  2.262-0.019  PaCO2 (P  .0251); diamonds, Qp/Qs  2.874-0.036  PaCO2 (P < .0001); circles, Qp/Qs 
4.585-0.081  PaCO2 (P < .0001); squares, Qp/Qs  3.415-0.072  PaCO2 (P  .0006). Particularly, the most valuable
negative correlation is observed in the dogs with an SS/BW ratio of 0.97 or 1.0. There is no significant correlation
in group L (B, SS/BW ratio of 1.1-1.4).
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Discussion
In a univentricular heart with systemic and pulmonary par-
allel competing circulations after first-stage Norwood pal-
liative surgery, the pulmonary blood flow depends on a
systemic–pulmonary arterial shunt, which is surgically cre-
ated. Current knowledge regarding the regulation of the
Figure 3. Relationship between arterial carbon dioxide tension (PaCO2) and systemic blood flow (Qs) of each dog.
There is a significant positive correlation and tendency in the dogs with an SS/BW ratio of 0.80, 0.97, and 1.0,
respectively. Squares, Qs  97.809  7.751  PaCO2 (P  .0038); diamonds, Qs  21.334  3.599  PaCO2 (P
< .0001); circles, Qs  40.849  1.866  PaCO2 (P  .0989). The most valuable correlation is observed in the dog
with an SS/BW ratio of 0.97. There is no significant correlation in other dogs with a shunt larger than an SS/BW
ratio of 1.0.
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pulmonary blood flow has derived not only from clinical
experience2,6-8,14 but also from animal experiments9-11,15,16
and hydromechanical studies.14,17,18 According to these in-
vestigations, it has become obvious that the pulmonary
blood flow in the univentricular hemodynamics is influ-
enced by the change of the pulmonary/systemic resistance
ratio, which could be controlled by FIO2, PaCO2, and inotro-
pic interventions.2,7,14-16 However, it is true that the exces-
sive pulmonary blood flow caused by an unreasonably large
or proximal systemic–pulmonary arterial shunt could not be
regulated simply by changes in such physiologic factors and
would result in cardiovascular collapse or death during the
first postoperative day.2,7,14
Mosca and colleagues7 suggested from their clinical ex-
perience that the major restriction to pulmonary blood flow
after a Norwood operation occurs within the innominate–
pulmonary artery shunt, and pulmonary vascular resistance
itself is relatively unimportant in determining pulmonary
blood flow, particularly that relevant to cardiovascular col-
lapse on the operative day. At this point the size and the
placement of systemic–pulmonary arterial shunt might be
more important than perioperative ventilatory and pharma-
cologic management.2,7 Our previous study with a simpli-
fied rigid model of the Norwood procedure demonstrated
that a central shunt constructed with a duct of 3.1 or 4.0 mm
in inner diameter would supply an excessive pulmonary
blood flow in neonates weighing 3.0 kg.14 Theoretically
speaking, the difference of the location of a proximal anas-
tomosis in a systemic–pulmonary arterial shunt among the
ascending aorta, the innominate artery, the innominate ar-
tery bifurcation, and the subclavian artery would be signif-
icantly related to the prevalence of excessive pulmonary
blood flow after a Norwood operation.19 We have therefore
suggested that in the Norwood procedure in small infants a
systemic–pulmonary arterial shunt should be constructed
with a prosthesis of 3.0 to 3.5 mm diameter from the
innominate artery.14 That recommendation is nearly com-
patible with these results.
Figure 4. Relationship between inspired oxygen fraction (FIO2) and pulmonary/systemic blood flow ratio (Qp/Qs
ratio) among group S (A, SS/BW ratio of 0.8-1.1) and group L (B, SS/BW ratio of 1.1-1.4). Data are presented as
mean  SD.
Figure 5. Relationship between base excess and pulmonary/systemic blood flow ratio (Qp/Qs ratio) among group
S (A, SS/BW ratio of 0.8-1.1) and group L (B, SS/BW ratio of 1.1-1.4).
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Jonas and colleagues2 reported in 1986 that a modified
Blalock-Taussig shunt with 4-mm polytetrafluoroethylene
graft would provide satisfactory flow so long as it was
placed sufficiently distally on the subclavian artery. How-
ever, Forbess and colleagues12 in the same institution re-
ported in 1995 that the patients with a 3.5-mm modified
Blalock-Taussig shunt were more likely to survive a first-
stage Norwood operation to a stage II procedure. Bartram
and associates20 reviewed 122 patients from 1980 to 1995
who died after a first-stage Norwood procedure at the same
hospital and reported that excessive pulmonary blood flow
was the second most common cause of death and occurred
significantly more often when the size of the modified
Blalock-Taussig shunt was 4 mm or greater than when the
size of shunt was 3.5 mm or less. Iannettoni,6 Mosca7 and
their colleagues advocated the tactics for the optimal shunt
size in a Norwood operation based on their experience.
Although a classic shunt was preferentially used only for a
too-small baby, a polytetrafluoroethylene conduit was usu-
ally anastomosed from the innominate artery to the central
pulmonary artery. Shunt size was determined by a general
rule that classic or 3.5-mm shunts were used in patients
weighing less than 3.5 kg and a 4.0-mm shunt was used in
those weighing more than 3.5 kg. Consequently, early mor-
tality has significantly improved, in contrast with results
obtained during the earlier years of their series in which
4.0-mm shunts had been commonly used.21 Bando and
coworkers13 adopted an another determination of the opti-
mal shunt size, and most patients weighing less than 4 kg
received a 3.5-mm conduit. As a result, operative survival in
patients with a 3.5-mm conduit improved significantly, and
larger shunt size (4 mm) was one of the significant risk
factors for early death.
Thus, favored use of a smaller shunt, such as 3.0 or 3.5
mm in diameter, for a systemic–pulmonary arterial shunt in
first-stage Norwood palliative surgery is the current trend in
preventing excessive pulmonary blood flow. However, spe-
cific management guidelines for suitable shunt size have not
yet been presented. This study demonstrated that the pul-
monary blood flow was controllable within physiologically
tolerable hemodynamic parameters by adjusting PaCO2 or FIO2
when the SS/BW ratio was 0.8 to 1.1; however, the pulmonary
blood flow became uncontrollably excessive even with such
adjustments when the SS/BW ratio was 1.1 to 1.4. Conse-
quently, each of the animals with SS/BW ratios of 0.8 to 1.0
received adequate Q˙ s; in contrast, SS/BW ratios of 1.0 to 1.4
resulted in inadequate Q˙ s and acidic status. If a patient 3.0 to
3.5 kg in body weight were to receive a 3.5-mm conduit shunt
such as is commonly used, the SS/BW ratio would be 1.0 to
1.17, and if such a patient were to receive a 4.0-mm conduit
shunt, the SS/BW ratio would be 1.14 to 1.33.
The factors that determine effective graft impedance are
many. The type of synthetic material, its distensibility, the
graft length, the way that the graft is sewn into the vessels,
and the exact takeoff point from the feeding vessel all
contribute to the impedance calculation. In neonates, exact
lie relative to the right pulmonary artery may be a factor;
this was avoided by sewing into the main pulmonary artery
in our model. The length of the shunt in this experimental
model was enormously longer than that seen in clinical
situation. According to our previous studies,14 changing the
length of a graft from 20 to 40 mm made little contribution
to the regulation of the pulmonary blood flow. A minute
change in the inner diameter of the systemic–pulmonary
arterial shunt, in contrast, exerted a great influence on the
pulmonary blood flow. We therefore suppose that the
SS/BW ratio of 1.1 provides an indication of whether pul-
monary blood flow can be regulated by physiologic respi-
ratory manipulation. To provide both Q˙ s and Q˙ p according
to our results, we believe that the SS/BW ratio of an ideal
shunt in the Norwood operation would 0.9 to 1.0. Because
grafts only come in 0.5-mm increments, the surgeon should
try to stay as close to this ratio as possible.
Three major limitations are present in this animal model:
species, age of animals, and single left ventricle physiology.
Dogs are different from human beings in terms of aortic
arch anatomy; that is, only two head vessels originate from
the dog’s aortic arch and the right subclavian artery is the
third branch of the first head vessel. Animals in this study
were not neonates, and they might possibly have weaker
pulmonary vascular responses than neonates to the changes
in the physiologic factors manipulated in the study.22 Al-
though the exclusion of the right ventricle from the circu-
lation by closure of the tricuspid valve closely approximates
the single ventricle physiology such as is seen after the
Norwood procedure, the single ventricle performing stroke
work is the left ventricle, not the right ventricle. This study
model must work on an inferior single ventricle physiology,
particularly with abruptly forced hypoxemic environment, im-
mediately after myocardial ischemia.6 A variation on the
model that would further increase statistical power would
involve two grafts in each animal (3.5 and 4 mm, for example),
alternating flow in each and making the series of measure-
ments. Then the effect of graft diameter could be determined
partially by using each animal as its own control. The interac-
tion of these differences could lead to a slightly different result.
In conclusion, when the SS/BW ratio is 0.8 to 1.1,
pulmonary blood flow after a Norwood operation is con-
trollable by changing PaCO2 and FIO2 values. However, an
unreasonably larger SS/BW ratio of 1.1 will produce exces-
sive pulmonary blood flow, which is uncontrollable by
physiologic respiratory manipulation. Although the site of
shunt anastomosis and individual variations must be con-
sidered, we recommend that 0.9 to 1.0 is a useful index
SS/BW value for suitable systemic–pulmonary arterial
shunt in the Norwood operation.
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